ESTIMATED
05/14/2024
05/14/2024
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.55 | -$0.55 | -$0.55 |
Q2 2024 | 1 | -$0.58 | -$0.58 | -$0.58 |
Q3 2024 | 0 | -$0.57 | -$0.57 | -$0.57 |
Q4 2024 | 0 | -$0.56 | -$0.56 | -$0.56 |
Q1 2025 | 0 | -$0.47 | -$0.47 | -$0.47 |
Q2 2025 | 0 | -$0.46 | -$0.46 | -$0.46 |
Q3 2025 | 0 | -$0.46 | -$0.46 | -$0.46 |
Q4 2025 | 0 | -$0.46 | -$0.46 | -$0.46 |
NRx Pharmaceuticals, Inc. last posted its earnings results on Tuesday, May 14th, 2024. The company reported $-0.74 earnings per share for the quarter, missing analysts' consensus estimates of $-0.55 by $0.19. The company had revenue of 0 for the quarter and had revenue of 0 for the year. NRx Pharmaceuticals, Inc. has generated $-4 earnings per share over the last year ($-3.98 diluted earnings per share) and currently has a price-to-earnings ratio of -0.89. NRx Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/14/2024 | Q1 2024 | -$0.55 | -$0.74 | -0.19 | $0 | $0 | 03/29/2024 | Q4 2023 | -$0.70 | -$0.05 | 0.65 | $8,000 | $8,000 | 09/29/2023 | Q3 2023 | -$0.07 | $0 | $0 | 08/14/2023 | Q2 2023 | -$1.40 | -$0.12 | 1.28 | $0 | 05/15/2023 | Q1 2023 | -$0.19 | $0 | 03/31/2023 | Q4 2022 | -$0.09 | $0 | 11/14/2022 | Q3 2022 | -$1.40 | -$0.14 | 1.26 | $0 | 08/15/2022 | Q2 2022 | -$1.00 | -$0.07 | 0.93 | $0 | 05/16/2022 | Q1 2022 | -$0.18 | $0 | 03/31/2022 | Q4 2021 | -$0.60 | $0 | 11/15/2021 | Q3 2021 | -$0.38 | $0 | 08/16/2021 | Q2 2021 | -$0.38 | $0 | 05/20/2021 | Q1 2021 | -$0.71 | $0 | 04/01/2021 | Q4 2020 | -$16.73 | $0 | 11/16/2020 | Q3 2020 | -$0.14 | $0 | 08/14/2020 | Q2 2020 | $0.00 | $0 | 05/15/2020 | Q1 2020 | $0.10 | $0 | 03/30/2020 | Q4 2019 | -$0.01 | $0 | 11/14/2019 | Q3 2019 | $0.02 | $0 | 08/14/2019 | Q2 2019 | $0.06 | $0 |
---|
A. NRx Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates.
A. The conference call for NRx Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for NRx Pharmaceuticals, Inc.'s latest earnings report can be read online.
A. NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) has a recorded net income of $0. NRx Pharmaceuticals, Inc. has generated $-3.98 earnings per share over the last four quarters.
A. NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) has a price-to-earnings ratio of -0.89 and price/earnings-to-growth ratio is 0.